Portugal, April 21 -- Portugal based LUSOPALEX - Produtos de Saude, Unipessoal Lda. has secured contract from Instituto Portugues do Sangue e da Transplantacao, IP for Blood-testing reagents Acquisition of Reagents for Defining ANTI-HLA Allosensitization in Clinical Histocompatibility from IPST IP during the years 2025 and 2026. The value of the contract is worth 149675500 EUR.
Published by HT Digital Content Services with permission from Pivotal Sources....